Stocktoria
Greenwich LifeSciences, Inc. GLSI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-25
Greenwich LifeSciences, Inc. statistics & valuation
Market cap$290.6M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -313.3% | -425.4% | -127.1% | -58.1% | -16.8% |
| Return on equity | -5480.5% | -1916.5% | -132.7% | -59.2% | -17.0% |
| Current ratio | 1.06 | 1.28 | — | — | — |
Source: SEC EDGAR filings · CIK 0001799788 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.